SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-021239
Filing Date
2022-08-04
Accepted
2022-08-04 07:26:21
Documents
71
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1569856
2 form10-q_001.jpg GRAPHIC 32157
3 ex31-1.htm EX-31.1 11507
4 ex31-2.htm EX-31.2 11205
5 ex32-1.htm EX-32.1 4472
6 ex32-2.htm EX-32.2 4513
  Complete submission text file 0001493152-22-021239.txt   5825402

Data Files

Seq Description Document Type Size
7 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prvb-20220630.xsd EX-101.SCH 41962
8 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prvb-20220630_cal.xml EX-101.CAL 53877
9 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prvb-20220630_def.xml EX-101.DEF 148929
10 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prvb-20220630_lab.xml EX-101.LAB 339775
11 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prvb-20220630_pre.xml EX-101.PRE 264439
65 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 775088
Mailing Address 55 BROAD STREET, 2ND FLOOR RED BANK NJ 07701
Business Address 55 BROAD STREET, 2ND FLOOR RED BANK NJ 07701 908-428-9136
Provention Bio, Inc. (Filer) CIK: 0001695357 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38552 | Film No.: 221134687
SIC: 2834 Pharmaceutical Preparations